Passionflower (Passiflora incarnata).

Passionflower's flavones and valerian's valerenic acid both act on GABA-A receptors, the nervous system's main calming channel, so the two support the body's wind-down through the same pathway. That shared target is the long-standing reason the pair is formulated together in traditional calming blends, with each contributing to GABA-A tone.

Rosmarinic acid from lemon balm inhibits GABA transaminase, slowing GABA breakdown, while passionflower flavonoids modulate the GABA-A receptor. Supply and receptor sides of the same system pair well.

Chamomile apigenin and passionflower chrysin are both flavones that bind the benzodiazepine site of the GABA-A receptor with low affinity. Traditional calming teas have combined them for centuries.

Apigenin is a partial ligand at the GABA-A benzodiazepine site, the same site passionflower chrysin acts on. Stacking them raises occupancy of one shared target rather than adding a mechanism.

Theanine raises GABA and glycine levels and blunts glutamate signalling from the transporter side, while passionflower acts at the receptor. The two reach the same inhibitory balance by different routes.

Passionflower flavonoids are positive modulators that need GABA present to have an effect. Supplemental GABA acts mostly on peripheral receptors, so the pairing is about tone rather than a single site.

Magnesium sits in the NMDA channel pore and reduces excitatory throughput, and glycine acts at its own inhibitory receptor. Both push the excitatory to inhibitory balance in the direction passionflower does.

Glycine is a fast inhibitory transmitter in brainstem and spinal circuits and also lowers core temperature before sleep. Its action complements the GABA-A modulation passionflower contributes.

Melatonin shifts circadian timing through MT1 and MT2 receptors, which is a different lever from GABAergic calming. Sleep formulas pair a timing signal with a calming agent for that reason.

Honokiol and magnolol are positive modulators at the GABA-A receptor at a site distinct from the benzodiazepine pocket. Combined with passionflower the effect on receptor tone adds up.

Kavalactones modulate GABA-A and sodium channel activity, so stacking them with passionflower flavonoids produces additive central calming. The combined dose should be set deliberately rather than by adding two full servings.

Tryptophan is the precursor for serotonin and then melatonin, a separate pathway from receptor modulation. Passionflower handles receptor tone while tryptophan supplies the substrate for evening signalling.

5-HTP bypasses the rate-limiting hydroxylation step on the way to serotonin. It is combined with passionflower so precursor supply and GABAergic tone are both addressed.

Hops strobiles and passionflower aerial parts appear together in long-standing European evening-tea and sleep-support formulas, usually alongside valerian. Hops contributes alpha acids and the prenylflavonoid fraction, chemistry entirely distinct from passionflower's flavone glycosides. The pairing rests on monograph-level traditional use rather than on a trial of the two alone.

Lavender preparations are used for tension and restlessness in the same context as passionflower and are frequently blended with it. Both are described as calming in traditional and monograph sources, so the combined effect on alertness could be greater than either alone. Anyone who needs to drive or operate machinery should account for that.

American skullcap is a standard companion to passionflower in nervine blends, and both are flavonoid-rich aerial-part herbs. Baicalin and baicalein from the Scutellaria genus have documented affinity for the benzodiazepine binding site in receptor assays. The pairing is conventional and the combination has not been isolated in a clinical study cited here.

Chrysin is one of the flavones present in Passiflora incarnata and is itself sold as a separate ingredient. In receptor binding work chrysin shows affinity for the benzodiazepine site of the GABA-A receptor without the full agonist profile of a drug. Adding isolated chrysin to a passionflower extract therefore concentrates one constituent the herb already contains.

Glutamate decarboxylase, the enzyme that converts glutamate to GABA, requires pyridoxal 5-phosphate as its cofactor. Passionflower is described as acting at the GABA-A receptor rather than on synthesis, so B6 supports the supply side of the same neurotransmitter system. The two touch different steps and neither substitutes for the other.

Magnesium blocks the NMDA receptor channel in a voltage-dependent way and is a required cofactor across the enzymes that support normal nerve signalling. That is the excitatory side of the balance, while passionflower flavonoids are described on the inhibitory GABA-A side. Combining them addresses the same balance from two directions.

Taurine is an agonist at both glycine and GABA-A receptors in electrophysiological work, the same inhibitory channels passionflower flavonoids are described as modulating. Two agents at the same receptor class raise the possibility of an additive effect on alertness, which is reasoning from receptor pharmacology rather than a measured result. The combination has not been studied clinically as far as the sources here go.

Ashwagandha withanolides are studied for effects on the hypothalamic-pituitary-adrenal axis and cortisol rhythm, a slower endocrine route than receptor-level modulation. Passionflower sits on the fast neurotransmitter side. Formulas combine them to cover both timescales, without a trial of the pair cited here.

Rhodiola is generally used for daytime alertness under load while passionflower is used in the evening, so the two are more often separated across the day than combined in one dose. Formulators who do combine them are balancing rather than stacking. The interaction is a timing question, not a pharmacological synergy.

Caffeine blocks adenosine receptors to raise arousal, which pulls in the opposite direction from a GABA-A modulating herb taken for evening calm. Taking both in the same window means each works against the other's intended use. This is a direct opposition worth flagging rather than a combination to build on.

St John's wort induces CYP3A4 and P-glycoprotein strongly, altering the clearance of many co-administered compounds including other botanical constituents. Anyone combining it with passionflower should regard the pairing as pharmacologically active rather than neutral. The two are also both used for mood-related support, so their effects on alertness may add.

Myo-inositol acts as a second messenger precursor in phosphoinositide signalling downstream of several neurotransmitter receptors, a different level of the system from passionflower's receptor-site modulation. Both appear in calm-support formulas. The combination is formulation convention with no combination trial cited.